HFE基因突变会阻止血清铁过载标志物阳性的慢性丙型肝炎患者对干扰素加利巴韦林产生持续病毒学应答。 - Suppr

HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.

作者信息

Coelho-Borges Silvia, Cheinquer Hugo, Cheinquer Nelson, Krug Luciano, Ashton-Prolla Patrícia

出版信息

Am J Gastroenterol. 2002 Jun;97(6):1570-2. doi: 10.1111/j.1572-0241.2002.05753.x.

DOI:10.1111/j.1572-0241.2002.05753.x

PMID:12094895

Abstract

摘要

相似文献

HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.

Am J Gastroenterol. 2002 Jun;97(6):1570-2. doi: 10.1111/j.1572-0241.2002.05753.x.

The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.

Med Sci Monit. 2010 Mar;16(3):CR137-143.

Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin.

Arq Gastroenterol. 2012 Jan-Mar;49(1):9-13. doi: 10.1590/s0004-28032012000100003.

Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C.

J Gastroenterol Hepatol. 2012 Jun;27(6):1112-6. doi: 10.1111/j.1440-1746.2011.06976.x.

The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.

Eur J Gastroenterol Hepatol. 2010 Oct;22(10):1204-10. doi: 10.1097/MEG.0b013e32833bec1e.

Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?

Gastroenterology. 2006 Nov;131(5):1635-8. doi: 10.1053/j.gastro.2006.09.034.

Iron overload and chronic hepatitis C: the role of HFE gene mutations.

Rev Esp Enferm Dig. 2003 Dec;95(12):819-28.

The H63D mutation of the hemochromatosis gene is associated with sustained virological response in chronic hepatitis C patients treated with interferon-based therapy: a meta-analysis.

Tohoku J Exp Med. 2012 Apr;226(4):293-9. doi: 10.1620/tjem.226.293.

Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection.

Liver. 2002 Jun;22(3):269-75. doi: 10.1046/j.0106-9543.2002.01672.x.

Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C.

J Viral Hepat. 2004 Mar;11(2):175-82. doi: 10.1046/j.1365-2893.2003.00488.x.

引用本文的文献

Hemochromatosis Gene Polymorphism as a Predictor of Sustained Virological Response to Antiviral Treatment in Egyptian Chronic Hepatitis C Patients.

Euroasian J Hepatogastroenterol. 2017 Jul-Dec;7(2):154-157. doi: 10.5005/jp-journals-10018-1238. Epub 2017 Sep 29.

Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

J Clin Exp Hepatol. 2012 Sep;2(3):211-7. doi: 10.1016/j.jceh.2012.06.004. Epub 2012 Sep 21.

The role of iron in the pathophysiology and treatment of chronic hepatitis C.

Can J Gastroenterol. 2009 Dec;23(12):822-8. doi: 10.1155/2009/290383.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献